levity compounded semaglutide reviews Demand Rising for 'Bootlegged' Weight-Loss

Others require higher doses

Wegovy (semaglutide) The Established Weekly Injectable or Oral Medication Wegovy is a once-weekly injectable GLP-1 receptor agonist with an established track record in clinical weight management

The drug's efficacy has underwhelmed investors since it has showed weight loss that is similar to Lilly's Zepbound and less than Lilly's retatrutide

GLP-3 (Reta) is not currently named on the WADA 2026 Prohibited List

Company officials stated that pharmacists will play a key role in helping members understand what starting GLP-1 therapy entails in daily practice, including guidance on side effects, hydration, nutrition, and realistic expectations

Why it matters: Gradual dosing is the best way to minimize common GI side effects (like nausea and constipation) and improve your chances of staying on the treatment long enough to see life-changing benefits